ROP
Roper Technologies Inc
NASDAQ NMS - GLOBAL MARKET· Technology· US· IPO 1992-02-13
$415.79
-2.52 (-0.60%)
last quote
Want the full multi-source brief on ROP?
The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.
Today
Open
$415.79
High
$423.06
Low
$415.01
Previous close
$418.31
Fundamentals
Market cap
$38.39B
P/E (TTM)
15.33x
P/S (TTM)
4.64x
P/B
2.41x
Gross margin
69.53%
Operating margin
27.97%
Net margin
30.24%
Rev growth (YoY)
10.88%
EPS growth (YoY)
69.50%
ROE
12.94%
52W high
$530.00
52W low
$305.96
Beta
0.71x
Industry peers
by market cap
Upcoming earnings
next 30 days
2026-10-21in 47 days
Q3 2026EPS est $5.85Rev est $2194.0M
Recent SEC filings
CIK 882835filing-language history →
Recent news
2026-08-27 → 2026-09-03
Yahoo · 16h
Roper Technologies to present at Goldman Sachs Technology Conference
SARASOTA, Fla., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) announced that it is presenting at the Goldman Sachs Communacopia + Technology Conference on Wednesday, September 9, 2026, at 8:10 AM (Pacific Time). A link to the webcast presentation will be available in the “Investors” section of the Company’s website at www.ropertech.com. About Roper Technologies Roper Te
Yahoo · 1d
Novartis Reports 3 Patient Deaths. Why the Stock Is Heading for Its Best Day Since 2023.
Novartis says it has paused clinical trials for rap-cel in patients with autoimmune disease, while reporting positive data for a different potential blockbuster.
Yahoo · 1d
Illumia Names Sean Bruton as Chief Information Security Officer
SCOTTSDALE, Ariz., September 01, 2026--Illumia, a leading provider of technology solutions that power payments, identity, commerce and foodservice operations across higher education, healthcare and corporate campuses, today announced the appointment of Sean Bruton as Chief Information Security Officer (CISO). Bruton brings more than 25 years of experience in cybersecurity and compliance leadership
Yahoo · 2d
3 Dividend Stocks with Unbelievable Streaks but Barely Pay Investors
Some dividend stocks boast decades of unbroken raise streaks yet leave income investors with almost nothing to show for it. These three companies sit in that strange category, and the tension between their legendary consistency and their near-invisible payouts reveals something important about what a dividend streak actually means.
Yahoo · 3d
Subsidised Access to Columvi® Now Available for Eligible Patients with Relapsed or Refractory DLBCL in Singapore
Columvi® (glofitamab) will be added to the Singapore Ministry of Health's (MOH) CDL and MAF List. Starting 1 September 2026, this milestone ensures that eligible Singaporeans and Permanent Residents will have subsidised access to the medication in public healthcare institutions.[1]
Yahoo · 5d
Roche Holding (SWX:ROP) Secures FDA Clearance For Alzheimer’s Blood Test
Roche Holding (SWX:ROP) received FDA approval for its Elecsys pTau217 blood test for Alzheimer's disease in the U.S. The Elecsys pTau217 test is designed to identify amyloid pathology using a blood sample, widening access to dementia diagnostics across U.S. labs. The FDA also cleared expanded use of Roche's PATHWAY HER2 and VENTANA HER2 Dual ISH tests in metastatic gastroesophageal cancers. These
Yahoo · 5d
Why Is Cognizant (CTSH) Up 18.3% Since Last Earnings Report?
Cognizant (CTSH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
SeekingAlpha · 6d
Best Dividend Aristocrats For September 2026
Dividend Aristocrats (NOBL) nearly match SPY in 2026, with top gainers, rising dividend growth, and 29 undervalued picksâsee which to buy now.
This is the free preview
The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.
Start the trial